Research Training
The Division of Child and Adolescent Psychiatry at Cincinnati Children's Hospital Medical Center has a strong interest in promoting clinical research experiences for residents. Residents may participate in protocols with faculty members.
Ongoing Research Studies
Ongoing studies currently by the Division of Child and Adolescent Psychiatry include:
- Double-Blind, Placebo-Controlled Study of an Antidepressant in Children and Adolescents with Generalized Anxiety Disorder
- Clonidine in ADHD Treatment
- Acetylcholinesterase Inhibitor in Treatment of ADHD
- Use of a Transdermal Patch in the Treatment of ADHD
- Antipsychotic in the Treatment of Adolescents with Mania
- Adolescent Body Dysphormic Disorder
- A Selective Irreversible Inhibitor of MAO-B
- SSRI Open-Label Treatment of Depression
- Open Label Extension Study of an SSRI Treatment in Depressed Adolescents and Children
- Open Label, Long-Term Safety Study of an Antidepressant in Children and Adolescents with Major Depressive Disorder
- Evaluation of PK, Safety and Tolerability of an Antidepressant in Pediatric and Adult Patients with Depression
- Multi-center, Double-blind, Placebo-Controlled Study of an Antidepressant in Depressed Adolescents
- Multi-center Study to Assess the Pharmacokinetics of an Anti-depressant in Children and Adolescents diagnosed with Depression or OCD
- Multi-center, Open-label Study to Assess Long-term Safety of an Antidepressant in Children and Adolescents with Depression or OCD
- Genetic Differences in Response to a Clomipramine in Patients with Obsessive Compulsive Disorder (OCD)
- Pulse Loaded, I.V. Clomipramine in Unresponsive Obsessive-Compulsive Disorder
- Randomized, Multi-center, 10 week, Double-Blind, Placebo-Controlled Flexible-Dose Study to Evaluate the Efficacy and Safety of a SSRI in Children and Adolescents with OCD
- 16 week, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Tolerability of an SSRI in the Treatment of Children and Adolescents with Social Anxiety Disorder / Social Phobia
- Antiparkinsonian Drug in Treatment of Tourettes Syndrome
- Controlled Comparison of an Antipsychotic and a Neuroleptic Drug
